Published in Surg Gynecol Obstet on August 01, 1990
Fundholding general practices. BMJ (1992) 7.19
Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg (1991) 3.32
Split-liver transplantation. The Paul Brousse policy. Ann Surg (1996) 1.35
Portal vein reconstruction in pediatric liver transplantation from living donors. Ann Surg (1998) 0.99
Pediatric liver transplantation. World J Gastroenterol (2009) 0.92
Liver transplantation in children. BMJ (1992) 0.75
Pediatric liver transplantation from neonatal donors. Transpl Int (1992) 0.75
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
24-hour and 72-hour preservation of canine kidneys. Lancet (1967) 3.81
Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci U S A (2000) 3.24
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med (1994) 2.93
Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89
A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci U S A (1992) 2.76
Cause of renal injury in kidneys obtained from cadaver donors. Surg Gynecol Obstet (1970) 2.20
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20
Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci U S A (1991) 2.17
Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science (1990) 2.00
Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res (1997) 2.00
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98
RS-61443--a phase I clinical trial and pilot rescue study. Transplantation (1992) 1.97
Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol (2001) 1.86
Preservation and transplantation of human cadaver kidneys: a two-year experience. Ann Surg (1970) 1.83
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
Etiology of rising perfusion pressure in isolated organ perfusion. Ann Surg (1968) 1.76
Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci U S A (2000) 1.72
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res (1994) 1.64
How common are various causes of dizziness? A critical review. South Med J (2000) 1.63
Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci (1999) 1.63
Nutrition and chronic lung disease. Am Rev Respir Dis (1985) 1.60
Intestinal necrosis and perforation after renal transplantation. Arch Surg (1975) 1.59
Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals. Proc Natl Acad Sci U S A (2001) 1.59
RS-61443--a new, potent immunosuppressive agent. Transplantation (1991) 1.57
Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol (1999) 1.56
Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta (1984) 1.55
Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res (1998) 1.55
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif (2009) 1.55
72-hour preservation of the canine pancreas. Transplantation (1987) 1.55
CT features of pulmonary alveolar proteinosis. AJR Am J Roentgenol (2001) 1.55
Treatment of symptomatic gastroesophageal reflux using the Angelchik prosthesis. Ann Surg (1982) 1.53
Successful extrarenal transplantation from non-heart-beating donors. Transplantation (1995) 1.53
Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med (1968) 1.52
High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci U S A (1976) 1.50
Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens (2004) 1.50
A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice. Int J Cancer (1992) 1.49
The feasibility of targeted selective gene therapy of the hair follicle. Nat Med (1995) 1.47
A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res (1999) 1.46
Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol (2001) 1.46
Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res (1993) 1.46
The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation (1991) 1.45
The correlation of MLC with graft survival. Transplant Proc (1973) 1.44
A ten year experience with cadaver kidney preservation using cryoprecipitated plasma. Am J Surg (1978) 1.44
A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res (1993) 1.44
Organ preservation. Annu Rev Med (1995) 1.43
Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am (1971) 1.40
In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci U S A (1986) 1.40
Factors affecting diabetes knowledge in Type 2 diabetic veterans. Diabetologia (2003) 1.39
Is there any role for antithymocyte induction in renal transplantation? Transplant Proc (2010) 1.39
Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin Exp Metastasis (1999) 1.38
Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models. Clin Exp Metastasis (2000) 1.38
Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res (1993) 1.37
In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis. Cancer Gene Ther (2000) 1.37
Pyramidal appearance and resistive index: insensitive and nonspecific sonographic indicators of renal transplant rejection. AJR Am J Roentgenol (1990) 1.36
Correlation between MLC stimulation and graft survival in living related and cadaver transplants. Ann Surg (1974) 1.36
Short term preservation of porcine livers. J Surg Res (1970) 1.34
Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution. Transplantation (1988) 1.33
Liver transplantation from controlled non-heart-beating donors. Surgery (2000) 1.32
Experience with simultaneous pancreas-kidney transplantation. Ann Surg (1988) 1.32
Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation (1995) 1.32
Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage. Ann Surg (1993) 1.31
In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci U S A (1987) 1.31
Clinical applications of the histoculture drug response assay. Clin Cancer Res (1995) 1.27
Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc Natl Acad Sci U S A (2001) 1.26
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis. Amino Acids (2001) 1.26
Improved patient survival in renal transplantation. Surgery (1976) 1.25
Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther (2001) 1.25
A metastatic orthotopic-transplant nude-mouse model of human patient breast cancer. Anticancer Res (1993) 1.24
Important components of the UW solution. Transplantation (1990) 1.24
Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res (1993) 1.22
Comparison between duodenal button and duodenal segment in pancreas transplantation. Transplantation (1989) 1.21
Step-down management of gastroesophageal reflux disease. Gastroenterology (2001) 1.20
Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res (1997) 1.18
Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med (1986) 1.18
Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci U S A (1995) 1.17
Is HL-A typing of clinical significance in cadaver renal transplantation? Lancet (1974) 1.17